Stockreport

Insmed: "Strong Buy" As Possible Label Expansion For ARIKAYCE Bodes Well [Seeking Alpha]

Insmed Incorporated  (INSM) 
Last insmed incorporated earnings: 4/30 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.insmed.com
PDF INSM is positioned to expand ARIKAYCE's label to 1st-line MAC patients [200k+], convert accelerated to full approval for refractory MAC, and pursue Japanese label expan [Read more]